TNFα and IL10 SNPs act together to predict disease behaviour in Crohn's disease

被引:49
作者
Fowler, EV [1 ]
Eri, R
Hume, G
Johnstone, S
Pandeya, N
Lincoln, D
Templeton, D
Radford-Smith, GL
机构
[1] Queensland Inst Med Res, Inflammatory Bowel Dis Lab, Clin Res Ctr, Royal Brisbane & Womens Hosp Res Fdn, Brisbane, Qld 4006, Australia
[2] Univ Queensland, Sch Med, Brisbane, Qld, Australia
[3] Royal Brisbane & Womans Hosp, Dept Gastroenterol, Brisbane, Qld, Australia
关键词
D O I
10.1136/jmg.2004.027425
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background: The cytokines tumour necrosis factor ( TNF) alpha and interleukin (IL) 10 have been implicated in the pathogenesis of Crohn's disease ( CD), with increased concentrations reported in patients with active disease. However, limited data exist on their effects on disease phenotype in the same population. Certain single nucleotide polymorphisms ( SNPs) within the promoter region of the IL10 (- 1082G/A, - 592C/ A) and TNF alpha (- 308G/A, - 857C/T) genes have been associated with altered levels of circulating IL10 and TNF alpha. Methods: We conducted an Australian based case - control study ( 304 CD patients; 231 healthy controls) of these four SNPs. Further investigation of two SNPs was conducted using a logistic regression analysis. Results: We identified a possible association of both IL10 SNPs and TNF alpha-857 with CD. Further investigation of a relationship with disease severity showed a significant association of higher producing IL10-1082G and TNF alpha-857C alleles with stricturing behaviour, which was strongest when these alleles were combined and persisted after multivariate analysis ( p = 0.007; odds ratio ( OR) 2.37, 95% CI 1.26 to 4.43). In addition, the TNF alpha-857CC genotype was independently associated with familial CD ( p = 0.03; OR 3.12; 95% CI 1.15 to 8.46). Conclusion: These two SNPs may help to predict disease behaviour in CD patients, which may be clinically useful in shaping treatment of the disease at an earlier stage.
引用
收藏
页码:523 / 528
页数:6
相关论文
共 36 条
[1]   An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation [J].
Asseman, C ;
Mauze, S ;
Leach, MW ;
Coffman, RL ;
Powrie, F .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (07) :995-1003
[2]   Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses [J].
Berg, DJ ;
Davidson, N ;
Kuhn, R ;
Muller, W ;
Menon, S ;
Holland, G ;
ThompsonSnipes, L ;
Leach, MW ;
Rennick, D .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (04) :1010-1020
[3]   INTERLEUKIN-10 ADMINISTRATION DECREASES SURVIVAL IN MURINE RECIPIENTS OF MAJOR HISTOCOMPATIBILITY COMPLEX DISPARATE DONOR BONE-MARROW GRAFTS [J].
BLAZAR, BR ;
TAYLOR, PA ;
SMITH, S ;
VALLERA, DA .
BLOOD, 1995, 85 (03) :842-851
[4]   TUMOR-NECROSIS-FACTOR-ALPHA IN STOOL AS A MARKER OF INTESTINAL INFLAMMATION [J].
BRAEGGER, CP ;
NICHOLLS, S ;
MURCH, SH ;
STEPHENS, S ;
MACDONALD, TT .
LANCET, 1992, 339 (8785) :89-91
[5]   Decreased lamina propria effector cell responsiveness to interleukin-10 in ileal Crohn's disease [J].
Colpaert, S ;
Vanstraelen, K ;
Liu, ZJ ;
Penninckx, F ;
Geboes, K ;
Rutgeerts, P ;
Ceuppens, J .
CLINICAL IMMUNOLOGY, 2002, 102 (01) :68-76
[6]   Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alfa [J].
Edwards-Smith, CJ ;
Jonsson, JR ;
Purdie, DM ;
Bansal, A ;
Shorthouse, C ;
Powell, EE .
HEPATOLOGY, 1999, 30 (02) :526-530
[7]   Crohn's disease:: an immunodeficiency? [J].
Folwaczny, C ;
Glas, J ;
Török, HP .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2003, 15 (06) :621-626
[8]   Novel variants of the IL-10 receptor 1 affect inhibition of monocyte TNF-α production [J].
Gasche, C ;
Grundtner, P ;
Zwirn, P ;
Reinisch, W ;
Shaw, SH ;
Zdanov, A ;
Sarma, U ;
Williams, LM ;
Foxwell, BM ;
Gangl, A .
JOURNAL OF IMMUNOLOGY, 2003, 170 (11) :5578-5582
[9]   A simple classification of Crohn's disease: Report of the Working Party for the world congresses of gastroenterology, Vienna 1998 [J].
Gasche, C ;
Scholmerich, J ;
Brynskov, J ;
D'Haens, G ;
Hanauer, SB ;
Irvine, EJ ;
Jewell, DP ;
Rachmilewitz, D ;
Sachar, DB ;
Sandborn, WJ ;
Sutherland, LR .
INFLAMMATORY BOWEL DISEASES, 2000, 6 (01) :8-15
[10]   TNF-α-308A promoter polymorphism is associated with enhanced TNF-α production and inflammatory activity in Crohn's patients with fistulizing disease [J].
González, S ;
Rodrigo, L ;
Martínez-Borra, J ;
López-Vázquez, A ;
Fuentes, D ;
Niño, P ;
Cadahía, V ;
Saro, C ;
Dieguez, MA ;
López-Larrea, C .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2003, 98 (05) :1101-1106